Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-25-194201
Filing Date
2025-09-03
Accepted
2025-09-02 18:09:01
Documents
11
Period of Report
2025-08-29

Document Format Files

Seq Description Document Type Size
1 6-K d85672d6k.htm 6-K 9765
2 EX-99.1 d85672dex991.htm EX-99.1 1504517
3 GRAPHIC g85672dsp15.jpg GRAPHIC 5781
4 GRAPHIC g85672dsp2.jpg GRAPHIC 6033
5 GRAPHIC g85672dsp3.jpg GRAPHIC 5813
6 GRAPHIC g85672dsp39a.jpg GRAPHIC 7556
7 GRAPHIC g85672dsp39b.jpg GRAPHIC 6827
8 GRAPHIC g85672dsp7.jpg GRAPHIC 7040
9 GRAPHIC g85672dsp87a.jpg GRAPHIC 1486
10 GRAPHIC g85672dsp89.jpg GRAPHIC 3355
11 GRAPHIC g85672dsp93.jpg GRAPHIC 8585
  Complete submission text file 0001193125-25-194201.txt   1589029
Mailing Address LEVEL 32, SUITE 32.07 AUSTRALIA SQUARE 264 GEORGE STREET SYDNEY, C3 NSW 2000
Business Address LEVEL 32, SUITE 32.07 AUSTRALIA SQUARE 264 GEORGE STREET SYDNEY, C3 NSW 2000 612 8315 7003
IMMUTEP Ltd (Filer) CIK: 0001506184 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-35428 | Film No.: 251286889
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)